The Roles of Tissue Rigidity and Its Underlying Mechanisms in Promoting Tumor Growth

References

• Kumar S, Weaver VM. Mechanics, malignancy, and metastasis: the force journey of a tumor cell. Cancer Metastasis Rev. 2009;28(1–2):113–127. doi:10.1007/s10555-008-9173-4.
   PubMed Web of Science ®Google Scholar
• Emon B, Bauer J, Jain Y, Jung B, Saif T. Biophysics of tumor microenvironment and cancer metastasis – a mini review. Comput Struct Biotechnol J. 2018;16:279–287. doi:10.1016/j.csbj.2018.07.003.
   PubMed Web of Science ®Google Scholar
• McAllister SS, Weinberg RA. The tumour-induced systemic environment as a critical regulator of cancer progression and metastasis. Nat Cell Biol. 2014;16(8):717–727. doi:10.1038/ncb3015.
   PubMed Web of Science ®Google Scholar
• Curry JM, Sprandio J, Cognetti D, Luginbuhl A, Bar-Ad V, Pribitkin E, et al. Tumor microenvironment in head and neck squamous cell carcinoma. Semin Oncol. 2014;41(2):217–234. doi:10.1053/j.seminoncol.2014.03.003.
   PubMed Web of Science ®Google Scholar
• Butcher DT, Alliston T, Weaver VM. A tense situation: forcing tumour progression. Nat Rev Cancer. 2009;9(2):108–122. doi:10.1038/nrc2544.
   PubMed Web of Science ®Google Scholar
• Dietrich C, Barr R, Farrokh A, Dighe M, Hocke M, Jenssen C, et al. Strain elastography – How to do it? Ultrasound Int Open. 2017;03(04):E137–E149. doi:10.1055/s-0043-119412.
   Google Scholar
• Reid SE, Kay EJ, Neilson LJ, Henze A, Serneels J, Mcghee EJ, et al. Tumor matrix stiffness promotes metastatic cancer cell interaction with the endothelium. Embo J. 2017;36(16):2373–2389. doi:10.15252/embj.201694912.
   PubMed Web of Science ®Google Scholar
• Lv Y, Chen C, Zhao B, Zhang X. Regulation of matrix stiffness on the epithelial-mesenchymal transition of breast cancer cells under hypoxia environment. Naturwissenschaften. 2017;104(5–6):38. doi:10.1007/s00114-017-1461-9.
   PubMed Web of Science ®Google Scholar
• Ruppender NS, Merkel AR, Martin TJ, Mundy GR, Julie A, Guelcher SA. Matrix rigidity induces osteolytic gene expression of metastatic breast cancer cells. PLoS One. 2010;5(11):e15451. doi:10.1371/journal.pone.0015451.
   PubMed Web of Science ®Google Scholar
• Provenzano PP, Inman DR, Eliceiri KW, Keely PJ. Matrix density-induced mechanoregulation of breast cell phenotype, signaling and gene expression through a FAK-ERK linkage. Oncogene. 2009;28(49):4326–4343. doi:10.1038/onc.2009.299.
   PubMed Web of Science ®Google Scholar
• Ondeck MG, Kumar A, Placone JK, Plunkett CM, Matte BF, Wong KC, et al. Dynamically stiffened matrix promotes malignant transformation of mammary epithelial cells via collective mechanical signaling. Proc Natl Acad Sci USA. 2019;116(9):3502–3507. doi:10.1073/pnas.1814204116.
   PubMed Web of Science ®Google Scholar
• Puls TJ, Tan X, Husain M, Whittington CF, Fishel ML, Voytik-Harbin SL. Development of a novel 3D tumor-tissue invasion model for high-throughput. Sci Rep. 2018;8(1):1–14. doi:10.1038/s41598-018-31138-6.
   PubMedGoogle Scholar
• Provenzano PP, Inman DR, Eliceiri KW, Knittel JG, Yan L, Rueden CT, et al. Collagen density promotes mammary tumor initiation and progression. BMC Med. 2008;6(1):11. doi:10.1186/1741-7015-6-11.
   PubMedGoogle Scholar
• Peng Y, Chen Z, Chen Y, Li S, Jiang Y, Yang H, et al. ROCK isoforms differentially modulate cancer cell motility by mechanosensing the substrate stiffness. Acta Biomater. 2019;88:86–101. doi:10.1016/j.actbio.2019.02.015.
   PubMed Web of Science ®Google Scholar
• Oellers P, Schröer U, Senner V, Paulus W, Thanos S. ROCKs are expressed in brain tumors and are required for glioma-cell migration on myelinated axons. Glia. 2009;57(5):499–509. doi:10.1002/glia.20777.
   PubMed Web of Science ®Google Scholar
• Masre SF, Rath N, Olson MF, Greenhalgh DA. Epidermal ROCK2-induces AKT1/GSK3β/β-catenin, NFκB and dermal tenascin-C; but enhanced differentiation and p53/p21 inhibit papilloma. Carcinogenesis. 2020. doi:10.1093/carcin/bgz205.
   PubMed Web of Science ®Google Scholar
• Mierke CT, Fischer T, Puder S, Kunschmann T, Soetje B, Ziegler WH. Focal adhesion kinase activity is required for actomyosin contractility-based invasion of cells into dense 3D matrices. Nat Publ Gr. 2017;7:1–18.
   Google Scholar
• Schrader J, Gordon-Walker TT, Aucott RL, van Deemter M, Quaas A, Walsh S, et al. Matrix stiffness modulates proliferation, chemotherapeutic response, and dormancy in hepatocellular carcinoma cells. Hepatology. 2011;53(4):1192–1205. doi:10.1002/hep.24108.
   PubMed Web of Science ®Google Scholar
• Wells RG. Tissue mechanics and fibrosis. Biochim Biophys Acta. 2013;1832(7):884–890. doi:10.1016/j.bbadis.2013.02.007.
   PubMed Web of Science ®Google Scholar
• Chen CS. Mechanotransduction – a field pulling together? J Cell Sci. 2008;121(Pt 20):3285–3292. doi:10.1242/jcs.023507.
   PubMed Web of Science ®Google Scholar
• Handorf AM, Zhou Y, Halanski MA, Li WJ. Tissue stiffness dictates development, homeostasis, and disease progression. Organogenesis. 2015;11(1):1–15. doi:10.1080/15476278.2015.1019687.
   PubMed Web of Science ®Google Scholar
• Janmey PA, Miller RT. Mechanisms of mechanical signaling in development and disease. J Cell Sci. 2011;124(Pt 1):9–18. doi:10.1242/jcs.071001.
   PubMed Web of Science ®Google Scholar
• Cox TR, Erler JT. Remodeling and homeostasis of the extracellular matrix: implications for fibrotic diseases and cancer. Dis Model Mech. 2011;4(2):165–178. doi:10.1242/dmm.004077.
   PubMed Web of Science ®Google Scholar
• Abdennour M, Reggio S, Le Naour G, Liu Y, Poitou C, Aron-Wisnewsky J, et al. Association of adipose tissue and liver fibrosis with tissue stiffness in morbid obesity: links with diabetes and BMI loss after gastric bypass. J Clin Endocrinol Metab. 2014;99(3):898–907. doi:10.1210/jc.2013-3253.
   PubMed Web of Science ®Google Scholar
• Plodinec M, Loparic M, Monnier CA, Obermann EC, Zanetti-Dallenbach R, Oertle P, et al. The nanomechanical signature of breast cancer. Nat Nanotechnol. 2012;7(11):757–765. doi:10.1038/nnano.2012.167.
   PubMed Web of Science ®Google Scholar
• Gao H, Aderhold A, Mangion K, Luo X, Husmeier D, Berry C. Changes and classification in myocardial contractile function in the left ventricle following acute myocardial infarction. J R Soc Interface. 2017;14(132):20170203. doi:10.1098/rsif.2017.0203.
   PubMed Web of Science ®Google Scholar
• Müller GJ, Wium CA, Marks CJ, Du Plessis CE, Veale DJH. Spider bite in southern Africa: diagnosis and management. Contin Med Educ. 2012;30: 382–391.
   Google Scholar
• Singh A, Brito I, Lammerding J. Beyond tissue stiffness and bioadhesivity: advanced biomaterials to model tumor microenvironments and drug resistance. Trends Cancer. 2018;4(4):281–291. doi:10.1016/j.trecan.2018.01.008.
   PubMed Web of Science ®Google Scholar
• Booth AJ, Hadley R, Cornett AM, Dreffs AA, Matthes SA, Tsui JL, et al. Acellular normal and fibrotic human lung matrices as a culture system for in vitro investigation. Am J Respir Crit Care Med. 2012;186(9):866–876. doi:10.1164/rccm.201204-0754OC.
   PubMed Web of Science ®Google Scholar
• Voutouri C, Mpekris F, Odysseos AD, Stylianopoulos T, Voutouri C, Papageorgis P. Role of constitutive behavior and tumor-host mechanical interactions in the state of stress and growth of solid tumors. PLoS One. 2014;9(8):e104717. doi:10.1371/journal.pone.0104717.
   PubMed Web of Science ®Google Scholar
• Munro D, Kallmeyer K, Almazyadi HAM, Thomford NE, Parker MI, Shipanga H, et al. The role of tumor microenvironment in chemoresistance: to survive, keep your enemies closer. IJMS. 2017;18(7):1586. doi:10.3390/ijms18071586.
   Google Scholar
• Nagelkerke A, Bussink J, Rowan AE, Span PN. The mechanical microenvironment in cancer: how physics affects tumours. Semin Cancer Biol. 2015;35:62–70. doi:10.1016/j.semcancer.2015.09.001.
   PubMed Web of Science ®Google Scholar
• Lin H-H, Lin H-K, Lin I-H, Chiou Y-W, Chen H-W, Liu C-Y, et al. Mechanical phenotype of cancer cells: cell softening and loss of stiffness sensing. Oncotarget. 2015;6(25):20946–20958. doi:10.18632/oncotarget.4173.
   PubMedGoogle Scholar
• Lekka M. Discrimination between normal and cancerous cells using AFM. Bionanoscience. 2016;6:65–80. doi:10.1007/s12668-016-0191-3.
   PubMed Web of Science ®Google Scholar
• Gkretsi V, Stylianou A, Papageorgis P, Polydorou C, Stylianopoulos T. Remodeling components of the tumor microenvironment to enhance cancer therapy. Front Oncol. 2015;5:214.
   PubMed Web of Science ®Google Scholar
• Polyak K, Haviv I, Campbell IG. Co-evolution of tumor cells and their microenvironment. Trends Genet. 2009;25(1):30–38. doi:10.1016/j.tig.2008.10.012.
   PubMed Web of Science ®Google Scholar
• Hanahan D, Coussens LM. Accessories to the crime: functions of cells recruited to the tumor microenvironment. Cancer Cell. 2012;21(3):309–322. doi:10.1016/j.ccr.2012.02.022.
   PubMed Web of Science ®Google Scholar
• Naba A, Clauser KR, Hoersch S, Liu H, Carr SA, Hynes RO. The matrisome: in silico definition and in vivo characterization by proteomics of normal and tumor extracellular matrices. Mol Cell Proteomics. 2012;11(4):M111.014647. doi:10.1074/mcp.M111.014647.
   PubMed Web of Science ®Google Scholar
• Frantz C, Stewart KM, Weaver VM. The extracellular matrix at a glance. J Cell Sci. 2010;123(Pt 24):4195–4200. doi:10.1242/jcs.023820.
   PubMed Web of Science ®Google Scholar
• Bussard KM, Mutkus L, Stumpf K, Gomez-Manzano C, Marini FC. Tumor-associated stromal cells as key contributors to the tumor microenvironment. Breast Cancer Res. 2016;18(1):11. doi:10.1186/s13058-016-0740-2.
   PubMedGoogle Scholar
• Watnick RS. The role of the tumor microenvironment in regulating angiogenesis. Cold Spring Harb Perspect Med. 2012;2(12):a006676. doi:10.1101/cshperspect.a006676.
   PubMed Web of Science ®Google Scholar
• Sun Y, Fan X, Zhang Q, Shi X, Xu G, Zou C. Cancer-associated fibroblasts secrete FGF-1 to promote ovarian proliferation, migration, and invasion through the activation of FGF-1/FGFR4 signaling. Tumor Biol. 2017;39:1–10.
   Google Scholar
• Yan Y, Wang LF, Wang RF. Role of cancer-associated fibroblasts in invasion and metastasis of gastric cancer. World J Gastroenterol. 2015;21(33):9717–9726. doi:10.3748/wjg.v21.i33.9717.
   PubMed Web of Science ®Google Scholar
• Sewell-Loftin MK, Bayer SVH, Crist E, Hughes T, Joison SM, Longmore GD, et al. Cancer-associated fibroblasts support vascular growth through mechanical force. Sci Rep. 2017;7(1):12. doi:10.1038/s41598-017-13006-x.
   PubMedGoogle Scholar
• Awaji M, Futakuchi M, Heavican T, Iqbal J, Singh RK. Cancer-associated fibroblasts enhance survival and progression of the aggressive pancreatic tumor via FGF-2 and CXCL8. Cancer Microenviron. 2019;12(1):37–46. doi:10.1007/s12307-019-00223-3.
   PubMed Web of Science ®Google Scholar
• Wang L, Cao L, Wang H, Liu B, Zhang Q, Meng Z, et al. Cancer-associated fibroblasts enhance metastatic potential of lung cancer cells through IL-6/STAT3 signaling pathway. Oncotarget. 2017;8(44):76116–76128. doi:10.18632/oncotarget.18814.
   PubMedGoogle Scholar
• Rattigan YI, Patel BB, Ackerstaff E, Sukenick G, Koutcher JA, Glod JW, et al. Lactate is a mediator of metabolic cooperation between stromal carcinoma associated fibroblasts and glycolytic tumor cells in the tumor microenvironment. Exp Cell Res. 2012;318(4):326–335. doi:10.1016/j.yexcr.2011.11.014.
   PubMed Web of Science ®Google Scholar
• Zhang A, Qian Y, Ye Z, Chen H, Xie H, Zhou L, et al. Cancer-associated fibroblasts promote M2 polarization of macrophages in pancreatic ductal adenocarcinoma. Cancer Med. 2017;6(2):463–470. doi:10.1002/cam4.993.
   PubMed Web of Science ®Google Scholar
• Xiong YQ, Sun HC, Zhang W, Zhu XD, Zhuang PY, Zhang JB, et al. Human hepatocellular carcinoma tumor-derived endothelial cells manifest increased angiogenesis capability and drug resistance compared with normal endothelial cells. Clin Cancer Res. 2009;15(15):4838–4846. doi:10.1158/1078-0432.CCR-08-2780.
   PubMed Web of Science ®Google Scholar
• Maishi N, Hida K. Tumor endothelial cells accelerate tumor metastasis. Cancer Sci. 2017;108(10):1921–1926. doi:10.1111/cas.13336.
   PubMed Web of Science ®Google Scholar
• Lokhov PG, Balashova EE. Tumor-induced endothelial cell surface heterogeneity directly affects endothelial cell escape from a cell-mediated immune response in vitro. Hum Vaccin Immunother. 2013;9(1):198–209. doi:10.4161/hv.22828.
   PubMed Web of Science ®Google Scholar
• Cao Z, Ding BS, Guo P, Lee SB, Butler JM, Casey SC, et al. Angiocrine factors deployed by tumor vascular niche induce B cell lymphoma invasiveness and chemoresistance. Cancer Cell. 2014;25(3):350–365. doi:10.1016/j.ccr.2014.02.005.
   PubMed Web of Science ®Google Scholar
• Sena IFG, Paiva AE, Prazeres PHDM, Azevedo PO, Lousado L, Bhutia SK, et al. Glioblastoma-activated pericytes support tumor growth via immunosuppression. Cancer Med. 2018;7(4):1232–1239. doi:10.1002/cam4.1375.
   PubMed Web of Science ®Google Scholar
• Bekes EM, Schweighofer B, Kupriyanova TA, Zajac E, Ardi VC, Quigley JP, et al. Tumor-recruited neutrophils and neutrophil TIMP-free MMP-9 regulate coordinately the levels of tumor angiogenesis and efficiency of malignant cell intravasation. Am J Pathol. 2011;179(3):1455–1470. doi:10.1016/j.ajpath.2011.05.031.
   PubMed Web of Science ®Google Scholar
• Mabuchi S, Yokoi E, Komura N, Kimura T. Myeloid-derived suppressor cells and their role in gynecological malignancies. Tumour Biol. 2018;40(7):1010428318776485. doi:10.1177/1010428318776485.
   Google Scholar
• McNally A, Hill GR, Sparwasser T, Thomas R, Steptoe RJ. CD4 + CD25+ regulatory T cells control CD8+ T-cell effector differentiation by modulating IL-2 homeostasis. Proc Natl Acad Sci USA. 2011;108(18):7529–7534. doi:10.1073/pnas.1103782108.
   PubMed Web of Science ®Google Scholar
• Bruno A, Pagani A, Pulze L, Albini A, Dallaglio K, Noonan DM, et al. Orchestration of angiogenesis by immune cells. Front Oncol. 2014;4:1–13.
   PubMedGoogle Scholar
• Grugan KD, McCabe FL, Kinder M, Greenplate AR, Harman BC, Ekert JE, et al. Tumor-associated macrophages promote invasion while retaining Fc-dependent anti-tumor function. J Immunol. 2012;189(11):5457–5466. doi:10.4049/jimmunol.1201889.
   PubMed Web of Science ®Google Scholar
• Gan L, Qiu Z, Huang J, Li Y, Huang H, Xiang T, et al. Cyclooxygenase-2 in tumor-associated macrophages promotes metastatic potential of breast cancer cells through akt pathway. Int J Biol Sci. 2016;12(12):1533–1543. doi:10.7150/ijbs.15943.
   PubMed Web of Science ®Google Scholar
• Smith HA, Kang Y. The metastasis-promoting roles of tumor-associated immune cells. J Mol Med. 2013;91(4):411–429. doi:10.1007/s00109-013-1021-5.
   PubMed Web of Science ®Google Scholar
• Yang C, He L, He P, Liu Y, Wang W, He Y, et al. Increased drug resistance in breast cancer by tumor-associated macrophages through IL-10/STAT3/bcl-2 signaling pathway. Med Oncol. 2015;32(2):352. doi:10.1007/s12032-014-0352-6.
   PubMed Web of Science ®Google Scholar
• Ruffell B, Chang-Strachan D, Chan V, Rosenbusch A, Ho CMT, Pryer N, et al. Macrophage IL-10 blocks CD8+ T cell-dependent responses to chemotherapy by suppressing IL-12 expression in intratumoral dendritic cells. Cancer Cell. 2014;26(5):623–637. doi:10.1016/j.ccell.2014.09.006.
   PubMed Web of Science ®Google Scholar
• Lu P, Weaver VM, Werb Z. The extracellular matrix: a dynamic niche in cancer progression. J Cell Biol. 2012;196(4):395–406. doi:10.1083/jcb.201102147.
   PubMed Web of Science ®Google Scholar
• Acerbi I, Cassereau L, Dean I, Shi Q, Au A, Park C, et al. Human breast cancer invasion and aggression correlates with ECM stiffening and immune cell infiltration. Integr Biol. 2015;7(10):1120–1134. doi:10.1039/c5ib00040h.
   Google Scholar
• Rath N, Olson MF. Regulation of pancreatic cancer aggressiveness by stromal stiffening. Nat Med. 2016;22(5):462–463. doi:10.1038/nm.4099.
   PubMed Web of Science ®Google Scholar
• Gilkes DM, Semenza GL, Wirtz D. Hypoxia and the extracellular matrix: drivers of tumour metastasis. Nat Rev Cancer. 2014;14(6):430–439. doi:10.1038/nrc3726.
   PubMed Web of Science ®Google Scholar
• Egeblad M, Rasch MG, Weaver VM. Dynamic interplay between the collagen scaffold and tumor evolution. Curr Opin Cell Biol. 2010;22(5):697–706. doi:10.1016/j.ceb.2010.08.015.
   PubMed Web of Science ®Google Scholar
• Naba A, Clauser KR, Lamar JM, Carr SA, Hynes RO. Extracellular matrix signatures of human mammary carcinoma identify novel metastasis promoters. Elife. 2014;3:e01308. doi:10.7554/eLife.01308.
   PubMed Web of Science ®Google Scholar
• Jain RK, Martin JD, Stylianopoulos T. The role of mechanical forces in tumor growth and therapy. Annu Rev Biomed Eng. 2014;16:321–346. doi:10.1146/annurev-bioeng-071813-105259.
   PubMed Web of Science ®Google Scholar
• Branton MH, Kopp JB. TGF-β and fibrosis. Microbes Infect. 1999;1(15):1349–1365. doi:10.1016/S1286-4579(99)00250-6.
   PubMed Web of Science ®Google Scholar
• Karagiannis GS, Diamandis EP, Kirsch R, Riddell RH, Poutahidis T, Erdman SE. Cancer-associated fibroblasts drive the progression of metastasis through both paracrine and mechanical pressure on cancer tissue. Mol Cancer Res. 2012;10(11):1403–1418. doi:10.1158/1541-7786.MCR-12-0307.
   PubMed Web of Science ®Google Scholar
• Stylianopoulos T, Martin JD, Snuderl M, Mpekris F, Jain SR, Jain RK. Coevolution of solid stress and interstitial fluid pressure in tumors during progression: implications for vascular collapse. Cancer Res. 2013;73(13):3833–3841. doi:10.1158/0008-5472.CAN-12-4521.
   PubMed Web of Science ®Google Scholar
• Heldin C-H, Rubin K, Pietras K, Östman A. High interstitial fluid pressure – an obstacle in cancer therapy. Nat Rev Cancer. 2004;4(10):806–813. doi:10.1038/nrc1456.
   PubMed Web of Science ®Google Scholar
• Yu T, Liu K, Wu Y, Fan J, Chen J, Li C, et al. High interstitial fluid pressure promotes tumor cell proliferation and invasion in oral squamous cell carcinoma. Int J Mol Med. 2013;32(5):1093–1100. doi:10.3892/ijmm.2013.1496.
   PubMed Web of Science ®Google Scholar
• Arif AB, Forde PF, Jahangeer S, Soden DM, Hinchion J. Releasing pressure in tumors: what do we know so far and where do we go from here? A review. Cancer Res. 2014;74:1–9.
   Web of Science ®Google Scholar
• Sarntinoranont M, Rooney F, Ferrari M. Interstitial stress and fluid pressure within a growing tumor. Ann Biomed Eng. 2003;31(3):327–335. doi:10.1114/1.1554923.
   PubMed Web of Science ®Google Scholar
• Hagendoorn J, Tong R, Fukumura D, Lin Q, Lobo J, Padera TP, et al. Onset of abnormal blood and lymphatic vessel function and interstitial hypertension in early stages of carcinogenesis. Cancer Res. 2006;66(7):3360–3364. doi:10.1158/0008-5472.CAN-05-2655.
   PubMed Web of Science ®Google Scholar
• Stylianopoulos T, Jain RK. Combining two strategies to improve perfusion and drug delivery in solid tumors. Proc Natl Acad Sci USA. 2013;110(46):18632–18637. doi:10.1073/pnas.1318415110.
   PubMed Web of Science ®Google Scholar
• Taloni A, Amar MB, Zapperi S, Porta CL. The role of pressure in cancer growth. Eur Phys J Plus. 2015;130:0–10.
   Web of Science ®Google Scholar
• Schedin P, Keely PJ. Mammary gland ECM remodeling, stiffness, and mechanosignaling in normal development and tumor progression. Cold Spring Harb Perspect Biol. 2011;3(1):a003228. doi:10.1101/cshperspect.a003228.
   PubMed Web of Science ®Google Scholar
• Lim Y, Lim S-T, Tomar A, Gardel M, Bernard-Trifilo JA, Chen XL, et al. PyK2 and FAK connections to p190Rho guanine nucleotide exchange factor regulate RhoA activity, focal adhesion formation, and cell motility. J Cell Biol. 2008;180(1):187–203. doi:10.1083/jcb.200708194.
   PubMed Web of Science ®Google Scholar
• Katoh K. Activation of Rho-kinase and focal adhesion kinase regulates the organization of stress fibers and focal adhesions in the central part of fibroblasts. PeerJ. 2017;5:e4063. doi:10.7717/peerj.4063.
   PubMed Web of Science ®Google Scholar
• Kalli M, Stylianopoulos T. Defining the role of solid stress and matrix stiffness in cancer cell proliferation and metastasis. Front Oncol. 2018;8:55. doi:10.3389/fonc.2018.00055.
   PubMed Web of Science ®Google Scholar
• Gkretsi V, Stylianopoulos T. Cell adhesion and matrix stiffness: coordinating cancer cell invasion and metastasis. Front Oncol. 2018;8:145. doi:10.3389/fonc.2018.00145.
   PubMed Web of Science ®Google Scholar
• Wei W-C, Lin H-H, Shen M-R, Tang M-J. Mechanosensing machinery for cells under low substratum rigidity. Am J Physiol Physiol. 2008;295:1579–1589.
   Web of Science ®Google Scholar
• Bae YH, Mui KL, Hsu BY, Liu SL, Cretu A, Razinia Z, et al. A FAK-Cas-Rac-lamellipodin signaling module transduces extracellular matrix stiffness into mechanosensitive cell cycling. Sci Signal. 2014;7:1–27.
   Web of Science ®Google Scholar
• Bell S, Terentjev EM. Focal adhesion kinase: the reversible molecular mechanosensor. Biophys J. 2017;112(11):2439–2450. doi:10.1016/j.bpj.2017.04.048.
   PubMed Web of Science ®Google Scholar
• Huveneers S, Danen EHJ. Adhesion signaling – crosstalk between integrins, Src and Rho. J Cell Sci. 2009;122(Pt 8):1059–1069. doi:10.1242/jcs.039446.
   PubMed Web of Science ®Google Scholar
• Schlaepfer DD, Broome MA, Hunter T. Fibronectin-stimulated signaling from a focal adhesion kinase-c-Src complex: involvement of the Grb2, p130cas, and Nck adaptor proteins. Mol Cell Biol. 1997;17(3):1702–1713. doi:10.1128/mcb.17.3.1702.
   PubMed Web of Science ®Google Scholar
• Lim ST, Chen XL, Tomar A, Miller NLG, Yoo J, Schlaepfer DD. Knock-in mutation reveals an essential role for focal adhesion kinase activity in blood vessel morphogenesis and cell motility-polarity but not cell proliferation. J Biol Chem. 2010;285(28):21526–21536. doi:10.1074/jbc.M110.129999.
   PubMed Web of Science ®Google Scholar
• Yeh Y, Ling J, Chen W, Lin H, Tang M. Mechanotransduction of matrix stiffness in regulation of focal adhesion size and number: reciprocal regulation of caveolin-1 and β 1 integrin. Sci Rep. 2017;7(1):1–14. doi:10.1038/s41598-017-14932-6.
   PubMedGoogle Scholar
• Mitra SK, Hanson DA, Schlaepfer DD. Focal adhesion kinase: in command and control of cell motility. Nat Rev Mol Cell Biol. 2005;6(1):56–68. doi:10.1038/nrm1549.
   PubMed Web of Science ®Google Scholar
• Rath N, Olson MF, Rock TR. Rho-associated kinases in tumorigenesis: re-considering ROCK inhibition for cancer therapy. EMBO Rep. 2012;13(10):900–908. doi:10.1038/embor.2012.127.
   PubMed Web of Science ®Google Scholar
• Sulzmaier FJ, Jean C, Schlaepfer DD, Jolla L. FAK in cancer: mechanistic findings and clinical applications. Nat Rev Cancer. 2014;14(9):598–610. doi:10.1038/nrc3792.
   PubMed Web of Science ®Google Scholar
• Shibue T, Brooks MW, Inan MF, Reinhardt F, Weinberg RA. The outgrowth of micrometastases is enabled by the formation of filopodium-like protrusions. Cancer Discov. 2012;2(8):706–721. doi:10.1158/2159-8290.CD-11-0239.
   PubMed Web of Science ®Google Scholar
• Van Miltenburg MHAM, Van Nimwegen MJ, Tijdens I, Lalai R, Kuiper R, Klarenbeek S, et al. Mammary gland-specific ablation of focal adhesion kinase reduces the incidence of p53-mediated mammary tumour formation. Br J Cancer. 2014;110(11):2747–2755. doi:10.1038/bjc.2014.219.
   PubMed Web of Science ®Google Scholar
• Cance WG, Golubovskaya VM. Focal adhesion kinase versus p53: apoptosis or survival? Sci Signal. Sci Signal. 2008;1(20):pe22. doi:10.1126/stke.120pe22.
   PubMed Web of Science ®Google Scholar
• Frisch SM, Vuori K, Ruoslahti E, Chan-Hui PY. Control of adhesion-dependent cell survival by focal adhesion kinase. J Cell Biol. 1996;134(3):793–799. doi:10.1083/jcb.134.3.793.
   PubMed Web of Science ®Google Scholar
• McKenzie AJ, Hicks SR, Svec KV, Naughton H, Edmunds ZL, Howe AK. The mechanical microenvironment regulates ovarian cancer cell morphology, migration, and spheroid disaggregation. Sci Rep. 2018;8(1):20. doi:10.1038/s41598-018-25589-0.
   PubMedGoogle Scholar
• Taliaferro-Smith L, Oberlick E, Liu T, McGlothen T, Alcaide T, Tobin R, et al. FAK activation is required for IGF1R-mediated regulation of EMT, migration, and invasion in mesenchymal triple negative breast cancer cells. Oncotarget. 2015;6(7):4757–4772. doi:10.18632/oncotarget.3023.
   PubMedGoogle Scholar
• Liu SQ, Xu CY, Wu WH, Fu ZH, He SW, Qin MB, et al. Sphingosine kinase 1 promotes the metastasis of colorectal cancer by inducing the epithelial-mesenchymal transition mediated by the FAK/AKT/MMPs axis. Int J Oncol. 2019;54(1):41–52. doi:10.3892/ijo.2018.4607.
   PubMed Web of Science ®Google Scholar
• Wu X, Gan B, Yoo Y, Guan JL. FAK-Mediated Src phosphorylation of endophilin A2 inhibits endocytosis of MT1-MMP and promotes ECM degradation. Dev Cell. 2005;9(2):185–196. doi:10.1016/j.devcel.2005.06.006.
   PubMed Web of Science ®Google Scholar
• Chen XL, Nam J-O, Jean C, Lawson C, Walsh CT, Goka E, et al. VEGF-induced vascular permeability is mediated by FAK. Dev Cell. 2012;22(1):146–157. doi:10.1016/j.devcel.2011.11.002.
   PubMed Web of Science ®Google Scholar
• Jean C, Chen XL, Nam J-O, Tancioni I, Uryu S, Lawson C, et al. Inhibition of endothelial FAK activity prevents tumor metastasis by enhancing barrier function. J Cell Biol. 2014;204(2):247–263. doi:10.1083/jcb.201307067.
   PubMed Web of Science ®Google Scholar
• Samuel MS, Lopez JI, Mcghee EJ, Croft DR, Strachan D, Timpson P, et al. Actomyosin-mediated cellular tension drives increased tissue stiffness and β-catenin activation to induce epidermal hyperplasia and tumor growth. Cancer Cell. 2011;19(6):776–791. doi:10.1016/j.ccr.2011.05.008.
   PubMed Web of Science ®Google Scholar
• Masre SF, Rath N, Olson MF, Greenhalgh DA. ROCK2/rasHa co-operation induces malignant conversion via p53 loss, elevated NF-κB and tenascin C-associated rigidity, but p21 inhibits ROCK2/NF-κB-mediated progression. Oncogene. 2017;36(18):2529–2542. doi:10.1038/onc.2016.402.
   PubMed Web of Science ®Google Scholar
• Amano M, Chihara K, Nakamura N, Kaneko T, Matsuura Y, Kaibuchi K. The COOH terminus of Rho-kinase negatively regulates rho-kinase activity. J Biol Chem. 1999;274(45):32418–32424. doi:10.1074/jbc.274.45.32418.
   PubMed Web of Science ®Google Scholar
• Samuel MS, Rath N, Masre SF, Boyle ST, Greenhalgh DA, Kochetkova M, et al. Tissue-selective expression of a conditionally-active ROCK2-estrogen receptor fusion protein. Genesis. 2016;54(12):636–646. doi:10.1002/dvg.22988.
   PubMed Web of Science ®Google Scholar
• Yang X, Di J, Zhang Y, Zhang S, Lu J, Liu J, et al. The Rho-kinase inhibitor inhibits proliferation and metastasis of small cell lung cancer. Biomed Pharmacother. 2012;66(3):221–227. doi:10.1016/j.biopha.2011.11.011.
   PubMed Web of Science ®Google Scholar
• Xu N, Liu F, Wu S, Ye M, Ge H, Zhang M, et al. CHD4 mediates proliferation and migration of non-small cell lung cancer via the RhoA/ROCK pathway by regulating PHF5A. BMC Cancer. 2020;20(1):11. doi:10.1186/s12885-020-06762-z.
   PubMed Web of Science ®Google Scholar
• Gandalovičová A, Vomastek T, Rosel D, Brábek J. Cell polarity signaling in the plasticity of cancer cell invasiveness. Oncotarget. 2016;7(18):25022–25049. doi:10.18632/oncotarget.7214.
   PubMedGoogle Scholar
• Zhu F, Zhang Z, Wu G, Li Z, Zhang R, Ren J, et al. Rho kinase inhibitor fasudil suppresses migration and invasion though down-regulating the expression of VEGF in lung cancer cell line A549. Med Oncol. 2011;28(2):565–571. doi:10.1007/s12032-010-9468-5.
   PubMed Web of Science ®Google Scholar
• Xue Y, Wu L, Liu Y, Ma Y, Zhang L, Ma X, et al. ENTPD5 induces apoptosis in lung cancer cells via regulating caspase 3 expression. PLoS One. 2015;10(3):e0120046. doi:10.1371/journal.pone.0120046.
   PubMed Web of Science ®Google Scholar
• Radziszewska A, Schroer SA, Choi D, Tajmir P, Radulovich N, Ho JC, et al. Absence of caspase-3 protects pancreatic {beta}-cells from c-Myc-induced apoptosis without leading to tumor formation. J Biol Chem. 2009;284(16):10947–10956. doi:10.1074/jbc.M806960200.
   PubMed Web of Science ®Google Scholar
• Chang Y-W, Bean R, Jakobi R. Targeting RhoA/Rho kinase and p21-activated kinase signaling to prevent cancer development and progression. Recent Pat Anticancer Drug Discov. 2009;4(2):110–124. doi:10.2174/157489209788452830.
   PubMed Web of Science ®Google Scholar
• Zhang Z, Ren JH, Li ZY, Nong L, Wu G. Fasudil inhibits lung carcinoma-conditioned endothelial cell viability and migration. Oncol Rep. 2012;27(5):1561–1566. doi:10.3892/or.2012.1686.
   PubMed Web of Science ®Google Scholar
• Lu X, Guo H, Chen X, Xiao J, Zou Y, Wang W, et al. Effect of RhoC on the epithelial-mesenchymal transition process induced by TGF-β1 in lung adenocarcinoma cells. Oncol Rep. 2016;36(6):3105–3112. doi:10.3892/or.2016.5146.
   PubMed Web of Science ®Google Scholar
• Jenkins RG, Su X, Su G, Scotton CJ, Camerer E, Laurent GJ, et al. Ligation of protease-activated receptor 1 enhances alpha(v)beta6 integrin-dependent TGF-beta activation and promotes acute lung injury. J Clin Invest. 2006;116(6):1606–1614. doi:10.1172/JCI27183.
   PubMed Web of Science ®Google Scholar
• Nam G, Lee EJ, Kim YK, Hong Y, Choi Y, Ryu M, et al. Combined Rho-kinase inhibition and immunogenic cell death triggers and propagates immunity against cancer. Nat Commun. 2018;9(1):15. doi:10.1038/s41467-018-04607-9.
   PubMedGoogle Scholar
• Wei L, Surma M, Shi S, Lambert-Cheatham N, Shi J. Novel Insights into the roles of Rho kinase in cancer. Arch Immunol Ther Exp (Warsz). 2016;64(4):259–278. doi:10.1007/s00005-015-0382-6.
   PubMed Web of Science ®Google Scholar
• Shi J, Wu X, Surma M, Vemula S, Zhang L, Yang Y, et al. Distinct roles for ROCK1 and ROCK2 in the regulation of cell detachment. Cell Death Dis. 2013;4:e483. doi:10.1038/cddis.2013.10.
   PubMed Web of Science ®Google Scholar
• Amano M, Nakayama M, Kaibuchi K. Rho-Kinase/ROCK: a key regulator of the cytoskeleton and cell polarity. Cytoskeleton (Hoboken). 2010;67(9):545–554. doi:10.1002/cm.20472.
   PubMed Web of Science ®Google Scholar
• Olson MF, Sahai E. The actin cytoskeleton in cancer cell motility. Clin Exp Metastasis. 2009;26(4):273–287. doi:10.1007/s10585-008-9174-2.
   PubMed Web of Science ®Google Scholar
• Riento K, Ridley AJ. Rocks: multifunctional kinases in cell behaviour. Nat Rev Mol Cell Biol. 2003;4(6):446–456. doi:10.1038/nrm1128.
   PubMed Web of Science ®Google Scholar
• Masre SF, Linkov N, Olson MF, Greenhalgh DA. Accelerated differentiation and p21/p53 responses to ROCK-mediated p-AKT/p-GSK3β/β-catenin overexpression prevent papillomas in transgenic mice. Brit J Dermatol. 2018;178:e409.
   Web of Science ®Google Scholar
• Liu S. The ROCK signaling and breast cancer metastasis. Mol Biol Rep. 2011;38(2):1363–1366. doi:10.1007/s11033-010-0238-4.
   PubMed Web of Science ®Google Scholar
• Liu X, Choy E, Hornicek FJ, Yang S, Yang C, Harmon D, et al. ROCK1 as a potential therapeutic target in osteosarcoma. J Orthop Res. 2011;29(8):1259–1266. doi:10.1002/jor.21403.
   PubMed Web of Science ®Google Scholar
• Yan S, Gao H, Meng H, Cheng L, Zhe L, Cao G, et al. Role of Rock 1 protein in non-small cell lung cancer. Biomed Res. 2017;28:2530–2434.
   Google Scholar
• Shin JY, Kim YI, Cho SJ, Lee MK, Kook MC, Lee JH, et al. MicroRNA 135a suppresses lymph node metastasis through down-regulation of ROCK1 in early gastric cancer. PLoS One. 2014;9(1):e85205. doi:10.1371/journal.pone.0085205.
   PubMed Web of Science ®Google Scholar
• Wang Y, Wang Y, Zhang Z. Adipokine RBP4 drives ovarian cancer cell migration. J Ovarian Res. 2018;11:1–10.
   PubMed Web of Science ®Google Scholar
• Wong CCL, Wong CM, Tung EKK, Man K, Ng IOL. Rho-kinase 2 is frequently overexpressed in hepatocellular carcinoma and involved in tumor invasion. Hepatology. 2009;49(5):1583–1594. doi:10.1002/hep.22836.
   PubMed Web of Science ®Google Scholar
• Dyberg CH, Fransson S, Andonova T, Sveinbjörnsson B, Lännerholm-Palm J, Forsberg D, et al. Abstract 5832: Rho-associated kinase is a therapeutic target in neuroblastoma. Cancer Res. 2017;77:5832. doi:10.1158/1538-7445.AM2017-5832.
   Web of Science ®Google Scholar
• Masre S, Olson M, Greenhalgh D. ROCK2 activation induces malignant conversion in rasHa-mediated transgenic mouse skin carcinogenesis via p53 loss, elevated nuclear factor-κβ and tenascin C-associated rigidity, but p21 inhibits early-stage progression. 2016;17:e55.
   Google Scholar
• Alkasalias T, Moyano-Galceran L, Arsenian-Henriksson M, Lehti K. Fibroblasts in the tumor microenvironment: shield or spear?. Int J Mol Sci. 2018;19:1–21.
   Web of Science ®Google Scholar
• Kalluri R. The biology and function of fibroblasts in cancer. Nat Rev Cancer. 2016;16(9):582–598. doi:10.1038/nrc.2016.73.
   PubMed Web of Science ®Google Scholar
• Busra FM, Lokanathan Y, Nadzir MM, Saim A, Idrus RBH, Chowdhury SR. Attachment, proliferation, and morphological properties of human dermal fibroblasts on ovine tendon collagen scaffolds: a comparative study. Malays J Med Sci. 2017;24(2):33–43. doi:10.21315/mjms2016.24.2.5.
   PubMed Web of Science ®Google Scholar
• Goffin JM, Pittet P, Csucs G, Lussi JW, Meister J-J, Hinz B. Focal adhesion size controls tension-dependent recruitment of α-smooth muscle actin to stress fibers. J Cell Biol. 2006;172(2):259–268. doi:10.1083/jcb.200506179.
   PubMed Web of Science ®Google Scholar
• Hinz B. Tissue stiffness, latent TGF-beta1 activation, and mechanical signal transduction: implications for the pathogenesis and treatment of fibrosis. Curr Rheumatol Rep. 2009;11(2):120–126. doi:10.1007/s11926-009-0017-1.
   PubMedGoogle Scholar
• Wu HJ, Hao M, Yeo SK, Guan JL. FAK signaling in cancer-associated fibroblasts promotes breast cancer cell migration and metastasis by exosomal miRNAs-mediated intercellular communication. Oncogene. 2020;39(12):2539–2549. doi:10.1038/s41388-020-1162-2.
   PubMed Web of Science ®Google Scholar
• Gaggioli C, Hooper S, Hidalgo-Carcedo C, Grosse R, Marshall JF, Harrington K, et al. Fibroblast-led collective invasion of carcinoma cells with differing roles for RhoGTPases in leading and following cells. Nat Cell Biol. 2007;9(12):1392–1400. doi:10.1038/ncb1658.
   PubMed Web of Science ®Google Scholar
• Li J, Jia Z, Kong J, Zhang F, Fang S, Li X, et al. Carcinoma-associated fibroblasts lead the invasion of salivary gland adenoid cystic carcinoma cells by creating an invasive track. PLoS One. 2016;11(3):e0150247. doi:10.1371/journal.pone.0150247.
   PubMed Web of Science ®Google Scholar
• Arora PD, Narani N, McCulloch CAG. The compliance of collagen gels regulates transforming growth factor-β induction of α-smooth muscle actin in fibroblasts. Am J Pathol. 1999;154(3):871–882. doi:10.1016/S0002-9440(10)65334-5.
   PubMed Web of Science ®Google Scholar
• Gillette M, Bray K, Blumenthaler A, Vargo-Gogola T. P190B RhoGAP overexpression in the developing mammary epithelium induces TGFβ-dependent fibroblast activation. PLoS One. 2013;8(5):e65105. doi:10.1371/journal.pone.0065105.
   PubMed Web of Science ®Google Scholar
• Lochter A, Galosy S, Muschler J, Freedman N, Werb Z, Bissell MJ. Matrix metalloproteinase stromelysin-1 triggers a cascade of molecular alterations that leads to stable epithelial-to-mesenchymal conversion and a premalignant phenotype in mammary epithelial cells. J Cell Biol. 1997;139(7):1861–1872. doi:10.1083/jcb.139.7.1861.
   PubMed Web of Science ®Google Scholar
• Wu X, Tao P, Zhou Q, Li J, Yu Z, Wang X, et al. IL-6 secreted by cancer-associated fibroblasts promotes epithelial-mesenchymal transition and metastasis of gastric cancer via JAK2/STAT3 signaling pathway. Oncotarget. 2017;8(13):20741–20750. doi:10.18632/oncotarget.15119.
   PubMedGoogle Scholar
• Vong S, Kalluri R. The role of stromal myofibroblast and extracellular matrix in tumor angiogenesis. Genes Cancer. 2011;2(12):1139–1145. doi:10.1177/1947601911423940.
   PubMedGoogle Scholar
• Knäuper V, Smith B, López-Otin C, Murphy G. Activation of progelatinase B (proMMP-9) by active collagenase-3 (MMP-13). Eur J Biochem. 1997;248(2):369–373. doi:10.1111/j.1432-1033.1997.00369.x.
   PubMedGoogle Scholar
• Teng F, Tian W-Y, Wang Y-M, Zhang Y-F, Guo F, Zhao J, et al. Cancer-associated fibroblasts promote the progression of endometrial cancer via the SDF-1/CXCR4 axis. J Hematol Oncol. 2016;9:8. doi:10.1186/s13045-015-0231-4.
   PubMed Web of Science ®Google Scholar
• Orimo A, Gupta PB, Sgroi DC, Arenzana-Seisdedos F, Delaunay T, Naeem R, et al. Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion. Cell. 2005;121(3):335–348. doi:10.1016/j.cell.2005.02.034.
   PubMed Web of Science ®Google Scholar
• Whipple CA, Brinckerhoff CE. BRAF(V600E) melanoma cells secrete factors that activate stromal fibroblasts and enhance tumourigenicity. Br J Cancer. 2014;111(8):1625–1633. doi:10.1038/bjc.2014.452.
   PubMed Web of Science ®Google Scholar
• Sugihara H, Ishimoto T, Yasuda T, Izumi D, Eto K, Sawayama H, et al. Cancer-associated fibroblast-derived CXCL12 causes tumor progression in adenocarcinoma of the esophagogastric junction. Med Oncol. 2015;32(6):618. doi:10.1007/s12032-015-0618-7.
   PubMed Web of Science ®Google Scholar
• Olumi A, Grossfeld G, Hayward S, Carroll P, Cunha G, Hein P, et al. Carcinoma-associated fibroblasts stimulate tumor progression of initiated human epithelium. Breast Cancer Res. 2000;2(S1):5002–5011. doi:10.1186/bcr138.
   Google Scholar
• Shook D, Keller R. Mechanisms, mechanics and function of epithelial-mesenchymal transitions in early development. Mech Dev. 2003;120(11):1351–1383. doi:10.1016/j.mod.2003.06.005.
   PubMed Web of Science ®Google Scholar
• Kalluri R. EMT: when epithelial cells decide to become mesenchymal-like cells. J Clin Invest. 2009;119(6):1417–1419. doi:10.1172/JCI39675.
   PubMed Web of Science ®Google Scholar
• Kang Y, Massagué J. Epithelial-mesenchymal transitions: twist in development and metastasis. Cell. 2004;118(3):277–279. doi:10.1016/j.cell.2004.07.011.
   PubMed Web of Science ®Google Scholar
• Wei SC, Yang J. Forcing through tumor metastasis: the interplay between tissue rigidity and epithelial – mesenchymal transition. Trends Cell Biol. 2016;26(2):111–120. doi:10.1016/j.tcb.2015.09.009.
   PubMed Web of Science ®Google Scholar
• Liu C-Y, Lin H-H, Tang M-J, Wang Y-K. Vimentin contributes to epithelial-mesenchymal transition cancer cell mechanics by mediating cytoskeletal organization and focal adhesion maturation. Oncotarget. 2015;6(18):15966–15983. doi:10.18632/oncotarget.3862.
   PubMedGoogle Scholar
• Guarino M, Rubino B, Ballabio G. The role of epithelial-mesenchymal transition in cancer pathology. Pathology. 2007;39(3):305–318. doi:10.1080/00313020701329914.
   PubMed Web of Science ®Google Scholar
• Thiery JP, Acloque H, Huang RYJ, Nieto MA. Epithelial-mesenchymal transitions in development and disease. Cell. 2009;139(5):871–890. doi:10.1016/j.cell.2009.11.007.
   PubMed Web of Science ®Google Scholar
• Gloushankova NA, Rubtsova SN, Zhitnyak IY. Cadherin-mediated cell–cell interactions in normal and cancer cells. Tissue Barriers. 2017;5(3):e1356900. doi:10.1080/21688370.2017.1356900.
   PubMed Web of Science ®Google Scholar
• Paoli P, Giannoni E, Chiarugi P. Anoikis molecular pathways and its role in cancer progression. Biochim Biophys Acta – Mol Cell Res. 2013;1833(12):3481–3498. doi:10.1016/j.bbamcr.2013.06.026.
   PubMed Web of Science ®Google Scholar
• Franco DL, Mainez J, Vega S, Sancho P, Murillo MM, de Frutos CA, et al. Snail1 suppresses TGF-beta-induced apoptosis and is sufficient to trigger EMT in hepatocytes. J Cell Sci. 2010;123(Pt 20):3467–3477. doi:10.1242/jcs.068692.
   PubMed Web of Science ®Google Scholar
• Fontemaggi G, Gurtner A, Strano S, Higashi Y, Sacchi A, Piaggio G, et al. The transcriptional repressor ZEB regulates p73 expression at the crossroad between proliferation and differentiation. Mol Cell Biol. 2001;21(24):8461–8470. doi:10.1128/MCB.21.24.8461-8470.2001.
   PubMed Web of Science ®Google Scholar
• Kudo-Saito C, Shirako H, Takeuchi T, Kawakami Y. Cancer metastasis is accelerated through immunosuppression during Snail-induced EMT of cancer cells. Cancer Cell. 2009;15(3):195–206. doi:10.1016/j.ccr.2009.01.023.
   PubMed Web of Science ®Google Scholar
• Rice AJ, Cortes E, Lachowski D, Cheung BCH, Karim SA, Morton JP, et al. Matrix stiffness induces epithelial-mesenchymal transition and promotes chemoresistance in pancreatic cancer cells. Oncogenesis. 2017;6(7):e352. doi:10.1038/oncsis.2017.54.
   PubMedGoogle Scholar
• Chen YQ, Lan HY, Wu YC, Yang WH, Chiou A, Yang MH. Epithelial-mesenchymal transition softens head and neck cancer cells to facilitate migration in 3D environments. J Cell Mol Med. 2018;22(8):3837–3846. doi:10.1111/jcmm.13656.
   Web of Science ®Google Scholar
• Piao J, You K, Guo Y, Youyi Z, Li Z, Li G. Substrate stiffness affects epithelial-mesenchymal transition of cervical cancer cells through miR-106b and its target protein DAB2. Int J Oncol. 2017;50(6):2033–2042. doi:10.3892/ijo.2017.3978.
   PubMed Web of Science ®Google Scholar
• Pang MF, Georgoudaki AM, Lambut L, Johansson J, Tabor V, Hagikura K, et al. TGF-β1-induced EMT promotes targeted migration of breast cancer cells through the lymphatic system by the activation of CCR7/CCL21-mediated chemotaxis. Oncogene. 2016;35(6):748–760. doi:10.1038/onc.2015.133.
   PubMed Web of Science ®Google Scholar
• Vu T, Datta PK. Regulation of EMT in colorectal cancer: a culprit in metastasis. Cancers. 2017;9(12):171. doi:10.3390/cancers9120171.
   PubMed Web of Science ®Google Scholar
• Wei SC, Fattet L, Tsai JH, Guo Y, Pai VH, Majeski HE, et al. Matrix stiffness drives epithelial-mesenchymal transition and tumour metastasis through a TWIST1-G3BP2 mechanotransduction pathway. Nat Cell Biol. 2015;17(5):678–688. doi:10.1038/ncb3157.
   PubMed Web of Science ®Google Scholar
• Matsuoka T, Yashiro M. Rho/ROCK signaling in motility and metastasis of gastric cancer. World J Gastroenterol. 2014;20(38):13756–13766. doi:10.3748/wjg.v20.i38.13756.
   PubMed Web of Science ®Google Scholar
• Sever R, Brugge JS. Signal transduction in cancer. Cold Spring Harb Perspect Med. 2015;5(4):a006098. doi:10.1101/cshperspect.a006098.
   PubMed Web of Science ®Google Scholar
• Pickup MW, Mouw JK, Weaver VM. The extracellular matrix modulates the hallmarks of cancer. EMBO Rep. 2014;15(12):1243–1253. doi:10.15252/embr.201439246.
   PubMed Web of Science ®Google Scholar
• Serrels A, Lund T, Serrels B, Byron A, McPherson RC, Von Kriegsheim A, et al. Nuclear FAK controls chemokine transcription, tregs, and evasion of anti-tumor immunity. Cell. 2015;163(1):160–173. doi:10.1016/j.cell.2015.09.001.
   PubMed Web of Science ®Google Scholar
• Ondondo B, Jones E, Godkin A, Gallimore A. Home sweet home: the tumor microenvironment as a haven for regulatory T cells. Front Immunol. 2013;4:1–9.
   PubMed Web of Science ®Google Scholar
• Goldstein JD, Pérol L, Zaragoza B, Baeyens A, Marodon G, Piaggio E. Role of cytokines in thymus- versus peripherally derived-regulatory T cell differentiation and function. Front Immunol. 2013;4:1–10.
   PubMed Web of Science ®Google Scholar
• Somasundaram R, Jacob L, Swoboda R, Caputo L, Song H, Basak S, et al. Inhibition of cytolytic T lymphocyte proliferation by autologous CD4+/CD25+ regulatory T cells in a colorectal carcinoma patient is mediated by transforming growth factor-β. Cancer Res. 2002;62:5267–5272.
   PubMed Web of Science ®Google Scholar
• Kitamura T, Qian BZ, Pollard JW. Immune cell promotion of metastasis. Nat Rev Immunol. 2015;15(2):73–86. doi:10.1038/nri3789.
   PubMed Web of Science ®Google Scholar
• Hoechst B, Voigtlaender T, Ormandy L, Gamrekelashvili J, Zhao F, Wedemeyer H, et al. Myeloid derived suppressor cells inhibit natural killer cells in patients with hepatocellular carcinoma via the NKp30 receptor Bastian. Hepatology. 2009;50(3):799–807. doi:10.1002/hep.23054.
   PubMed Web of Science ®Google Scholar
• Jachetti E, Caputo S, Mazzoleni S, Brambillasca CS, Parigi SM, Grioni M, et al. Tenascin-C protects cancer stem-like cells from immune surveillance by arresting T-cell activation. Cancer Res. 2015;75(10):2095–2108. doi:10.1158/0008-5472.CAN-14-2346.
   PubMed Web of Science ®Google Scholar
• Klement JD, Paschall AV, Redd PS, Ibrahim ML, Lu C, Yang D, et al. An osteopontin/CD44 immune checkpoint controls CD8+ T cell activation and tumor immune evasion. J Clin Invest. 2018;128(12):5549–5560. doi:10.1172/JCI123360.
   PubMed Web of Science ®Google Scholar
• Wight TN, Kang I, Evanko SP, Harten IA, Chang MY, Pearce OMT, et al. Versican – a critical extracellular matrix regulator of immunity and inflammation. Front Immunol. 2020;11:1–12.
   PubMed Web of Science ®Google Scholar
• Evanko SP, Potter-Perigo S, Bollyky PL, Nepom GT, Wight TN. Hyaluronan and versican in the control of human T-lymphocyte adhesion and migration. Matrix Biol. 2012;31(2):90–100. doi:10.1016/j.matbio.2011.10.004.
   PubMed Web of Science ®Google Scholar
• Kuczek DE, Larsen AMH, Thorseth ML, Carretta M, Kalvisa A, Siersbæk MS, et al. Collagen density regulates the activity of tumor-infiltrating T cells. J Immunother Cancer. 2019;7(1):15. doi:10.1186/s40425-019-0556-6.
   PubMedGoogle Scholar
• Kaur A, Ecker BL, Douglass SM, Kugel CH, Webster MR, Almeida FV, et al. Remodeling of the collagen matrix in aging skin promotes melanoma metastasis and affects immune cell motility. Cancer Discov. 2019;9(1):64–81. doi:10.1158/2159-8290.CD-18-0193.
   PubMed Web of Science ®Google Scholar
• Huang JJ, Blobe GC. Dichotomous roles of TGF-β in human cancer. Biochem Soc Trans. 2016;44(5):1441–1454. doi:10.1042/BST20160065.
   PubMedGoogle Scholar
• Cicchini C, Laudadio I, Citarella F, Corazzari M, Steindler C, Conigliaro A, et al. TGFbeta-induced EMT requires focal adhesion kinase (FAK) signaling. Exp Cell Res. 2008;314(1):143–152. doi:10.1016/j.yexcr.2007.09.005.
   PubMed Web of Science ®Google Scholar
• Li W, Zhang B, Li H, Zhao C, Zhong Y, Sun J, et al. TGF β1 mediates epithelial mesenchymal transition via β6 integrin signaling pathway in breast cancer. Cancer Invest. 2014;32(8):409–415. doi:10.3109/07357907.2014.933235.
   PubMed Web of Science ®Google Scholar
• Tauriello DVF, Palomo-Ponce S, Stork D, Berenguer-Llergo A, Badia-Ramentol J, Iglesias M, et al. TGFβ drives immune evasion in genetically reconstituted colon cancer metastasis. Nature. 2018;554(7693):538–543. doi:10.1038/nature25492.
   PubMed Web of Science ®Google Scholar
• Mariathasan S, Turley SJ, Nickles D, Castiglioni A, Yuen K, Wang Y, et al. TGFβ attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells. Nature. 2018;554(7693):544–548. doi:10.1038/nature25501.
   PubMed Web of Science ®Google Scholar
• Thomas DA, Massagué J. TGF-beta directly targets cytotoxic T cell functions during tumor evasion of immune surveillance. Cancer Cell. 2005;8(5):369–380. doi:10.1016/j.ccr.2005.10.012.
   PubMed Web of Science ®Google Scholar
• Chen X. l, Chen Z. q, Zhu S. l, Liu T. w, Wen Y, Su Y. s, et al. Prognostic value of transforming growth factor-beta in patients with colorectal cancer who undergo surgery: a meta-analysis. BMC Cancer. 2017;17(1):11. doi:10.1186/s12885-017-3215-7.
   PubMedGoogle Scholar
• Li J, Shen C, Xin W, Lai Y, Zhou K, Li P, et al. Prognostic value of TGF-β in lung cancer: a systematic review and meta-analysis. BMC Cancer. 2019;19(1):691. doi:10.1186/s12885-019-5917-5.
   PubMedGoogle Scholar
• de Kruijf EM, Dekker TJA, Hawinkels LJAC, Putter H, Smit V, Kroep JR, et al. The prognostic role of TGF-β signaling pathway in breast cancer patients. Ann Oncol. 2013;24(2):384–390. doi:10.1093/annonc/mds333.
   PubMed Web of Science ®Google Scholar
• Bordeleau F, Mason BN, Lollis EM, Mazzola M, Zanotelli MR, Somasegar S, et al. Matrix stiffening promotes a tumor vasculature phenotype. Proc Natl Acad Sci USA. 2017;114(3):492–497. doi:10.1073/pnas.1613855114.
   PubMed Web of Science ®Google Scholar
• Tilghman RW, Cowan CR, Mih JD, Koryakina Y, Gioeli D, Slack-Davis JK, et al. Matrix rigidity regulates cancer cell growth and cellular phenotype. PLoS One. 2010;5(9):e12905. doi:10.1371/journal.pone.0012905.
   PubMed Web of Science ®Google Scholar
• Marangon I, Silva AAK, Guilbert T, Kolosnjaj-Tabi J, Marchiol C, Natkhunarajah S, et al. Tumor stiffening, a key determinant of tumor progression, is reversed by nanomaterial-induced photothermal therapy. Theranostics. 2017;7(2):329–343. doi:10.7150/thno.17574.
   PubMed Web of Science ®Google Scholar
• Levental KR, Yu H, Kass L, Lakins JN, Egeblad M, Erler JT, et al. Matrix crosslinking forces tumor progression by enhancing integrin signaling. Cell. 2009;139(5):891–906. doi:10.1016/j.cell.2009.10.027.
   PubMed Web of Science ®Google Scholar
• Garber K. Stromal depletion goes on trial in pancreatic cancer. J Natl Cancer Inst. 2010;102(7):448–450. doi:10.1093/jnci/djq113.
   PubMedGoogle Scholar
• Zhang R, Ma M, Dong G, Yao RR, Li JH, Zheng QD, et al. Increased matrix stiffness promotes tumor progression of residual hepatocellular carcinoma after insufficient heat treatment. Cancer Sci. 2017;108(9):1778–1786. doi:10.1111/cas.13322.
   PubMed Web of Science ®Google Scholar
• Zhang SX, Liu L, Zhao W. Targeting biophysical cues: a Niche approach to study, diagnose, and treat cancer. Trends Cancer. 2018;4(4):268–271. doi:10.1016/j.trecan.2018.02.006.
   PubMed Web of Science ®Google Scholar